Cancer patients exhibiting high levels of heparanase had a significantly shorter postoperative survival time than patients whose tumors contained low levels of heparanase due, in part, to increased tumor metastasis and tumor angiogenesis [5]. This evidence concerns the gene HPSE and neoplasm.